Previous Article | Next Article 
Journal of Virology, May 2005, p. 5963-5970, Vol. 79, No. 10
0022-538X/05/$08.00+0 doi:10.1128/JVI.79.10.5963-5970.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Human Rhinovirus Type 89 Variants Use Heparan Sulfate Proteoglycan for Cell Attachment
Markete Vlasak,
Irene Goesler, and
Dieter Blaas*
Max F. Perutz Laboratories, University Departments at the Vienna Biocenter, Department of Medical Biochemistry, Medical University of Vienna, Dr. Bohr Gasse 9/3, A-1030 Vienna, Austria
Received 12 August 2004/
Accepted 23 December 2004
We have previously isolated mutants of the major-group human rhinovirus type 89 that grow in cells deficient in intercellular adhesion molecule 1 (ICAM-1), the receptor used by the wild-type virus for cell entry [A. Reischl, M. Reithmayer, G. Winsauer, R. Moser, I. Goesler, and D. Blaas., J. Virol. 75:9312-9319, 2001]. We now demonstrate that one of these variants utilizes heparan sulfate proteoglycan (HSPG) as a cellular receptor. Adaptation to ICAM-1-deficient cells not only resulted in the newly acquired receptor specificity but also rendered the virus less stable at low pH and at elevated temperatures. This instability might compensate for the absence of the uncoating activity of ICAM-1. Whereas wild-type virus infection via ICAM-1 proceeded in the presence of the vesicular H+-ATPase inhibitor bafilomycin A1, infection by the mutant via HSPG was prevented by the drug. This suggests that the low pH prevailing in endosomal compartments is required for uncoating in the absence of the catalytic activity of ICAM-1.
* Corresponding author. Mailing address: Max F. Perutz Laboratories, University Departments at the Vienna Biocenter, Department of Medical Biochemistry, Medical University of Vienna, Dr. Bohr Gasse 9/3, A-1030 Vienna, Austria. Phone: 43 1 4277 61630. Fax: 43 1 4277 9616. E-mail:
dieter.blaas{at}meduniwien.ac.at.
Journal of Virology, May 2005, p. 5963-5970, Vol. 79, No. 10
0022-538X/05/$08.00+0 doi:10.1128/JVI.79.10.5963-5970.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Blomqvist, S., Savolainen-Kopra, C., Paananen, A., Hovi, T., Roivainen, M.
(2009). Molecular characterization of human rhinovirus field strains isolated during surveillance of enteroviruses. J. Gen. Virol.
90: 1371-1381
[Abstract]
[Full Text]
-
Guy, M., Chilmonczyk, S., Cruciere, C., Eloit, M., Bakkali-Kassimi, L.
(2009). Efficient infection of buffalo rat liver-resistant cells by encephalomyocarditis virus requires binding to cell surface sialic acids. J. Gen. Virol.
90: 187-196
[Abstract]
[Full Text]
-
Khan, A. G., Pichler, J., Rosemann, A., Blaas, D.
(2007). Human Rhinovirus Type 54 Infection via Heparan Sulfate Is Less Efficient and Strictly Dependent on Low Endosomal pH. J. Virol.
81: 4625-4632
[Abstract]
[Full Text]
-
Behling-Kelly, E., Vonderheid, H., Kim, K. S., Corbeil, L. B., Czuprynski, C. J.
(2006). Roles of Cellular Activation and Sulfated Glycans in Haemophilus somnus Adherence to Bovine Brain Microvascular Endothelial Cells. Infect. Immun.
74: 5311-5318
[Abstract]
[Full Text]
-
Zautner, A. E., Jahn, B., Hammerschmidt, E., Wutzler, P., Schmidtke, M.
(2006). N- and 6-O-Sulfated Heparan Sulfates Mediate Internalization of Coxsackievirus B3 Variant PD into CHO-K1 Cells.. J. Virol.
80: 6629-6636
[Abstract]
[Full Text]
-
Vlasak, M., Roivainen, M., Reithmayer, M., Goesler, I., Laine, P., Snyers, L., Hovi, T., Blaas, D.
(2005). The Minor Receptor Group of Human Rhinovirus (HRV) Includes HRV23 and HRV25, but the Presence of a Lysine in the VP1 HI Loop Is Not Sufficient for Receptor Binding. J. Virol.
79: 7389-7395
[Abstract]
[Full Text]